0.01
+19.23%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About CV Sciences
From its filings with the US Securities and Exchange Commission
CV Sciences is based in San Diego, California and is incorporated in Delaware. Its shares trade on OTC under the ticker CVSI. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2025, it reported revenue of $13.8m and a net loss of $958,000. At that date it held total assets of $7.0m and shareholders' equity of $1.5m.
CV Sciences, Inc. (“CV Sciences,” the “Company,” “we,” “our” or “us”) is a consumer wellness company specializing in nutraceuticals and plant-based foods. Our hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (“B2B”) to business-to-consumer (“B2C”).
On December 7, 2023, we entered into a Membership Interest Purchase Agreement, pursuant to which we purchased all of the outstanding equity interests in Cultured Foods Sp. z.o.o. (“Cultured Foods”), resulting in Cultured Foods becoming a wholly owned subsidiary of the Company. Cultured Foods is a leading European manufacturer and distributor of plant-based protein products. In January 2025, we launched Lunar Fox, a brand that is focused on distribution of plant-based products in the U.S. market. Our Cultured Foods and Lunar Fox brands provide a variety of 100% plant-based food products. Committed to crafting nutritious and flavorful alternatives, Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience.
Quoted from its 10-K, filed 26 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 4 Oct 2018
- Employees
- 36
- Website
- cvsciences.com ↗
- Head office
- 9530 PADGETT STREET, SAN DIEGO, CA, 92126
- Incorporated in
- DE
- Classification
- Pharmaceutical Preparations
- Filer status
- Non-accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Joseph DowlingChief Executive Officer, Secretary, Director, since 2014$457,667
- Mr. Joerg GrasserChief Financial Officer$343,322
- Dr. Jamie CorroonIndependent Director$44,471
- Mr. William MccorkleIndependent Director$44,471
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- CV Sciences Inc has a strong brand reputation in the health and wellness industry.
- The company has a diverse product portfolio, ranging from CBD-based supplements to pharmaceuticals.
- CV Sciences Inc has established strong relationships with suppliers, ensuring a consistent supply chain.
Weaknesses
- The company is heavily reliant on the regulatory environment, as changes in legislation can impact its operations.
- Limited distribution channels may hinder market penetration and growth potential for CV Sciences Inc.
- The company faces intense competition from both established players and new entrants in the CBD market.
Opportunities
- Expanding consumer awareness and acceptance of CBD-based products present significant growth opportunities for CV Sciences Inc.
- International expansion into emerging markets could help the company diversify its revenue streams.
- Collaborations with healthcare professionals and institutions could enhance the credibility and reach of CV Sciences Inc's products.
Threats
- Changing regulations and uncertain legal frameworks pose risks to CV Sciences Inc's operations.
- Counterfeit products and low-quality competitors could undermine the company's brand reputation.
- Negative public perception and misconceptions surrounding CBD products may limit market growth and consumer adoption.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.